Clover Health Investments Corp
NASDAQ:CLOV
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
US |
Clover Health Investments Corp
NASDAQ:CLOV
|
438.4m USD | -3.8 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
483.7B USD | 35.1 | ||
US |
Elevance Health Inc
NYSE:ELV
|
127.2B USD | 41 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 18.3 | ||
US |
Humana Inc
NYSE:HUM
|
42.9B USD | -20.3 | ||
US |
Centene Corp
NYSE:CNC
|
41.8B USD | 21.7 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20.4B USD | 23.2 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 64.4 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
33.8B BRL | -98.4 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 37.7 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
2.7B USD | 14.4 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.